CBD oil in MCT (25%)

Natural THC-free broad spectrum cannabidiol produced in Switzerland

Our CBD oil in MCT oil contains 25 % broad spectrum cannabidiol (2500 mg CBD), extracted from certified Swiss hemp. This THC-free formulation combines CBD with light-absorbing MCT oil, ideal for cosmetic skin care. The bottle comes with a medical pipette for easy and accurate dosage.

Benefits and effects

CBD oil dissolved in the MCT gives the skin natural fatty acids that are quickly absorbed and can help keep the skin balanced and moist. MCT oil is known for its medium triglycerides that supply the skin, while CBD can have soothing properties, making the oil particularly suitable for dry or sensitive skin. Note: This product is only intended for cosmetic use and not for intake.

Ingredients and content

• Ingredients: MCT oil, broad spectrum CBD oil (2500 mg cannabidiol from Swiss hemp)
• Content per bottle: 10 ml, corresponding to approx. 270 drops
• THC content: 0.0 % - laboratory tested and confirmed THC -free

Manual

Shake the bottle well before use. Apply a few drops to the desired skin area morning and evening for best results. For new users, it is recommended to start with a low dose to assess the skin's response. Store in a cool, dry place, protected from direct sunlight to preserve the quality.

Quality control and test results

All our CBD products undergo strict quality controls. This CBD oil is the laboratory test in Switzerland to confirm cannabinoid content and microbiological safety, as well as to ensure the absence of heavy metals, pesticides and other contaminants. We collaborate with a British partner who delivers biodegradable packaging, which supports our environmentally friendly approach and ensures a sustainable production chain.

Reservation

Only for adults over 18 years. Not recommended for pregnant or breastfeeding without medical approval. This product is intended for cosmetic use and not for oral administration. Uno Vita AS makes no medical claims about the effect of the product. We always recommend consulting health professionals before use if you have medical conditions or use prescription medications.

Freedom of speech and right to information

Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like in accordance with laws on freedom of speech. This includes:

• UN World Declaration of Human Rights (1948): Article 19
• The International Convention on Civil and Political Rights (1966): Article 19
• Norwegian Constitution § 100
• US First Amendment

Relevant references:

1. Huestis, M. A. (2007). Human cannabinoid pharmacokinetics.
2. Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids.
3. Mechoulam, R., & Parker, L. A. (2013). The Endocannabinoid System and the Brain.
4. Russo, E. B. (2011). Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects.
5. Pertwee, R. G. (2006). Cannabinoid pharmacology.
6. Pisanti, S., et al. (2017). Cannabidiol: State of the Art and New Challenges for Therapeutic Applications.
7. McPartland, J. M., et al. (2015). Cannabidiol modulation of the endocannabinoid system.
8. Zuardi, A. W. (2008). Cannabidiol: A Drug With a Wide Spectrum of Action.
9. Pamplona, ​​F. A., et al. (2018). The anti-inflammatory properties of cannabidiol.
10. Shannon, S., et al. (2019). Cannabidiol in anxiety and sleep.
11. Ashton, C. H. (2001). Effects of cannabis: A brief review.
12. Pertwee, R. G., et al. (2018). Cannabinoids in health and disease.